Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rhythm Pharmaceuticals Inc.

61.74
+0.40000.65%
Post-market: 61.740.00000.00%19:05 EDT
Volume:628.86K
Turnover:38.70M
Market Cap:3.90B
PE:-14.23
High:61.96
Open:61.11
Low:60.93
Close:61.34
Loading ...

Rhythm Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
18 Mar

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration

GlobeNewswire
·
18 Mar

Stifel Nicolaus Sticks to Its Buy Rating for Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
11 Mar

Rhythm Pharmaceuticals Coverage Assumed by Morgan Stanley at Overweight

Dow Jones
·
08 Mar

Promising Outlook for Rhythm Pharmaceuticals: Buy Rating Backed by Positive Phase 3 Study Expectations and Market Potential

TIPRANKS
·
07 Mar

Rhythm Pharmaceuticals Price Target Announced at $78.00/Share by Stifel

Dow Jones
·
06 Mar

Rhythm Pharmaceuticals Inc : Stifel Resumes Coverage With Buy Rating; Price Target $78

THOMSON REUTERS
·
05 Mar

US High Growth Tech Stocks to Watch in March 2025

Simply Wall St.
·
05 Mar

Rhythm Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.
·
03 Mar

Rhythm Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
03 Mar

Rhythm Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $70 From $69

THOMSON REUTERS
·
03 Mar

Rhythm Pharmaceuticals Faces Financial Risks Due to Convertible Preferred Stock Prioritization

TIPRANKS
·
01 Mar

Rhythm Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
28 Feb

We Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business Growth

Simply Wall St.
·
27 Feb

Rhythm Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St.
·
27 Feb

Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
27 Feb

Q4 2024 Rhythm Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
27 Feb

Analysts Offer Insights on Healthcare Companies: Nuvalent (NUVL) and Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
27 Feb

Stock Track | Rhythm Pharmaceuticals Soars 5.01% as Q4 Sales Beat Estimates, Drug Prospects Raise Hopes

Stock Track
·
27 Feb

Rhythm Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb